Clin2
NCT07810023Possibly a fitEnrolling by invitation

Ketamine shot for suicidal distress in the emergency room

SuicidalSuicidal IdeationSuicidal Ideation and BehaviorDepression / Major Depressive Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether a single ketamine injection can quickly reduce suicidal thoughts in people waiting to be admitted to the psychiatric unit. Ketamine is a fast-acting medication that may help calm the mind during a crisis.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
8 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are in the Evanston Hospital emergency room and waiting to be admitted to the psychiatric unit.
  • You are not pregnant.
  • You do not have a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder with psychosis.
  • You are not currently in the ER because of a suicide attempt that caused physical harm.
  • You do not have a current or significant history of substance abuse.
  • You have not had a bad reaction to ketamine or esketamine before.
  • You do not have unstable vital signs (like high blood pressure that is not controlled).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06085937Recruiting· Phase 1
Ketamine for suicidal patients in the ER

This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.

Kansas City, Kansas
NCT07868913Recruiting· Phase 2
Ketamine and therapy for suicidal thoughts in the ER

This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.

Fort Hood, Texas
NCT06891300Recruiting· Phase 2/Phase 3
Ketamine for Suicidal Thoughts in Depression

This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.

Ottawa, Ontario
NCT07569198Recruiting· Phase 2
Ketamine plus therapy for depression with suicidal thoughts

This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.

Toronto, Ontario
NCT05696691Recruiting· Phase 2/Phase 3
Ketamine with a crisis plan for suicidal thoughts in the ER

This study tests whether ketamine plus a structured crisis-response plan can help reduce suicidal thoughts for adults admitted from the ER. It also aims to make care in the emergency setting more consistent and effective.

San Antonio, Texas
NCT07139106Not yet recruiting· Phase 4
Ketamine for suicidal thoughts in depression

This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.

New York, New York

Hear when a new Suicidal trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.